The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05500222
Brief Title: A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

First Submitted : August 11, 2022
First Submitted that Met QC Criteria : August 11, 2022
First Posted : August 15, 2022

Last Update Submitted that Met QC Criteria : March 21, 2024
Last Update Posted : March 25, 2024